(Q40088833)

17 September 2017

Saperconazole therapy in a rabbit model of invasive aspergillosis (English)

1 reference

17 September 2017

0 references

Patterson TF

1

1 reference

17 September 2017

George D

series ordinal

2

1 reference

17 September 2017

Miniter P

series ordinal

3

1 reference

17 September 2017

Andriole VT

series ordinal

4

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 December 1992

1 reference

Antimicrobial Agents and Chemotherapy

17 September 2017

1 reference

17 September 2017

36

1 reference

17 September 2017

12

1 reference

17 September 2017

2681-2685

1 reference

Oral and parenteral therapy with saperconazole (R 66905) of invasive aspergillosis in normal and immunocompromised animals

17 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245528

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245528

Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245528

Effect of cyclodextrin on the pharmacology of antifungal oral azoles

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245528

Treatment of invasive aspergillosis with itraconazole

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245528

The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245528

In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245528

17 June 2018

1 reference

12 December 2020

Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191

1 reference

12 December 2020

New antifungal agents

1 reference

12 December 2020

Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes.

1 reference

12 December 2020

Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model

1 reference

12 December 2020

The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.36.12.2681

1 reference

17 September 2017

1 reference

17 September 2017

PubMed publication ID

1482137

1 reference